HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombotic thrombocytopenic purpura with severe neurological impairment: remission after Rituximab.

AuthorsF Magalini, A Stella, M Basaglia, R Vescovini, M Sassi, A Maria Lombardi, P Sansoni
JournalTransfusion medicine (Oxford, England) (Transfus Med) Vol. 21 Issue 2 Pg. 140-3 (Apr 2011) ISSN: 1365-3148 [Electronic] England
PMID21118315 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Anticonvulsants
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Rituximab
  • Vincristine
Topics
  • Adult
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Anticonvulsants (therapeutic use)
  • Consciousness Disorders (etiology)
  • Diagnosis, Differential
  • Encephalitis (diagnosis)
  • Epilepsy, Tonic-Clonic (etiology)
  • Fecal Incontinence (etiology)
  • Hallucinations (etiology)
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Male
  • Plasma Exchange
  • Purpura, Thrombotic Thrombocytopenic (complications, drug therapy, therapy)
  • Remission Induction
  • Rituximab
  • Urinary Incontinence (etiology)
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: